U.S. Army Medical Department
USAMRIID Banner

About USAMRIID

Scientific Publications

Medical Library

Business Opportunities

Employment

Education & Training

Biosafety

Reference Materials

Related Links

Newsroom/Media

Contact Us

Search

>>  Home  >>  Scientific Publications  >>  2009


20132012201120102009200820072006200520042003200220012000


— 2009 —

Alkhalil A; Strand S; Mucker E; Huggins JW; Jahrling PB; Ibrahim SM.  Inhibition of monkeypox virus replication by RNA interference.  Virology journal 2009, 6: 188

Aman MJ; Kinch MS; Warfield K; Warren T; Yunus A; Enterlein S; Stavale E; Wang P; Chang S; Tang Q; Porter K; Goldblatt M; Bavari S.  Development of a broad-spectrum antiviral with activity against Ebola virus.  Antiviral research 2009 Sep, 83(3): 245-51

Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ.  CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.  Vaccine 2009 Apr 6, 27(16): 2220-9

Baldwin CD, Howe GB, Sampath R, Blyn LB, Matthews H, Harpin V, Hall TA, Drader JJ, Hofstadler SA, Eshoo MW, Rudnick K, Studarus K, Moore D, Abbott S, Janda J, Whitehouse CA.  Usefulness of multilocus polymerase chain reaction followed by electrospray ionization mass spectrometry to identify a diverse panel of bacterial isolates.  Diagnostic microbiology and infectious disease 2009 Apr, 63(4): 403-8

Burke RL; Whitehouse CA; Taylor JK; Selby EB.  Epidemiology of invasive Klebsiella pneumoniae with hypermucoviscosity phenotype in a research colony of nonhuman primates.  Comparative medicine 2009 Dec, 59(6): 589-97

Cer RZ; Mudunuri U; Stephens R; Lebeda FJ.  IC50-to-K-i: a web-based tool for converting IC50 to K-i values for inhibitors of enzyme activity and ligand binding.   Nucleic Acids Research 2009 July 1, 37 (Suppl. S): W441-W445

Coleman RE, Hochberg LP, Swanson KI, Lee JS, McAvin JC, Moulton JK, Eddington DO, Groebner JL, O'Guinn ML, Putnam JL.  Impact of phlebotomine sand flies on U.S. military operations at Tallil Air Base, Iraq: 4.  Detection and identification of leishmania parasites in sand flies.  Journal of Medical Entomology 2009 May; 46(3): 649-63.

Cote CK; Bozue J; Twenhafel N; Welkos SL.  Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model.  Journal of medical microbiology 2009 Jun, 58(Pt 6): 816-25

DiMezzo TL, Ruthel G, Brueggemann EE, Hines HB, Ribot WJ, Chapman CE, Powell BS, Welkos SL.  In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis.  PloS One 2009, 4(7): e6281

Dupuy LC, Locher CP, Paidhungat M, Richards MJ, Lind CM, Bakken R, Parker MD, Whalen RG, Schmaljohn CS.  Directed molecular evoluation improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.  Vaccine 2009 Jun 24; 27(31): 4152-60.

Dupuy LC; Schmaljohn CS.  DNA vaccines for biodefense.  Expert review of vaccines 2009 Dec, 8(12): 1739-54

Ezzell JW, Abshire TG, Panchal R, Chabot D, Bavari S, Leffel EK, Purcell B, Friedlander AM, Ribot WJ.  Association of Bacillus anthracis Capsule with Lethal Toxin during Experimental Infection.  Infection and immunity 2009 Feb, 77(2): 749-755

Friedlander AM; Little SF.  Advances in the development of next-generation anthrax vaccines.  Vaccine 2009 Nov 5, 27 (Suppl 4): D28-32

Garza NL; Hatkin JM; Livingston V; Nichols DK; Chaplin PJ; Volkmann A; Fisher D; Nalca A.  Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.  Vaccine 2009 Sep 4, 27(40): 5496-504

Gelhaus HC; Rozak DA; Nierman WC; Chen D; Mojgan Z; John JV; Ulrich RL; Adamovicz JJ.  Exogenous Yersinia pestis quorum sensing molecules N-octanoyl-homoserine lactone and N-(3-oxooctanoyl)-homoserine lactone regulate the LcrV virulence factor.  Microbial pathogenesis 2009 May; 46(5): 283-7

Hartman LJ; Selby EB; Whitehouse CA; Coyne SR; Jaissle JG; Twenhafel NA; Burke RL; Kulesh DA.  Rapid real-time PCR assays for detection of Klebsiella pneumoniae with the rmpA or magA genes associated with the hypermucoviscosity phenotype: screening of nonhuman primates.  Journal of molecular diagnostics 2009 Sep, 11(5): 464-71

Hooper JW; Ferro AM; Golden JW; Silvera P; Dudek J; Alterson K; Custer M; Rivers B; Morris J; Owens G; Smith JF; Kamrud KI.  Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.  Vaccine 2009 Dec 11, 28(2): 494-511

Howe GB; Loveless BM; Norwood D; Craw P; Waag D; England M; Lowe JR; Courtney BC; Pitt ML; Kulesh DA.  Real-time PCR for the early detection and quantification of Coxiella burnetii as an alternative to the murine bioassay.  Molecular and Cellular Probes 2009 June-Aug, 23(3-4): 127-131

Huzella LM, Buckley MJ, Alves DA, Stiles BG, Krakauer T.  Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: A new mouse model.  Research in veterinary science 2009 Apr, 86(2): 241-7

Jenkins AL; Worsham PL; Welkos SL.  A strategy to verify the absence of the pgm locus in Yersinia pestis strain candidates for select agent exemption.  Journal of microbiological methods 2009 Jun, 77 (3): 316-9

Kalina WV; Warfield KL; Olinger GG; Bavari S.  Discovery of common marburgvirus protective epitopes in a BALB/c mouse model.  Virology journal 2009, 6: 132

Keasey SL, Schmid KE, Lee MS, Meegan J, Tomas P, Minto M, Tikhonov AP, Schweitzer B, Ulrich RG.  Extensive antibody cross-reactivity among infectious gram-negative bacteria revealed by proteome microarray analysis.  Molecular and Cellular Proteomics 2009 May; 8(5): 924-35

Krakauer T; Buckley MJ; Huzella LM; Alves DA.  Critical timing, location and duration of glucocorticoid administration rescue mice from superantigen-induced shock and attenuate lung injury.  International immunopharmacology 2009 Sep, 9(10): 1168-74

Larkin EA; Carman RJ; Krakauer T; Stiles BG.  Staphylococcus aureus:  the toxic presence of a pathogen extraordinaire.  Current medicinal chemistry 2009, 16(30): 4003-19

Loveless BM, Mucker EM, Hartmann C, Craw PD, Huggins J, Kulesh DA.  Differentiation of Variola major and Variola minor variants by MGB-Eclipse probe melt curves and genotyping analysis.  Molecular and Cellular Probes 2009 June-August; 23(3-4): 166-70

Ludivico ML; Smith LA; Ahmed SA.  Structure-based design of peptide inhibitors of botulinum neurotoxin serotype A proteolytic activity.  The Botulinum Journal 2009; 1(3): 297-308

McKinney MD, Moon SJ, Kulesh DA, Larsen T, Schoepp RJ.  Detection of viral RNA from paraffin-embedded tissues after prolonged formalin fixation.  Journal of clinical virology 2009 Jan, 44(1): 39-42

Natesan M; Cooper MA; Tran JP; Rivera VR; Poli MA.  Quantitative detection of staphylococcal enterotoxin B by resonant acoustic profiling.  Analytical chemistry 2009 May 15, 81(10): 3896-902

Olinger GG, Biggins JE, Melanson MR, Wahl-Jensen V, Geisbert TW, Hensley EL.  Drug targets in infections with Ebola and Marburg viruses.  Infectious Disorders Drug Targets 2009 April; 9(2): 191-200

Panchal RG; Ulrich RL; Lane D; Butler MM; Houseweart C; Opperman T; Williams JD; Peet NP; Moir DT; Nguyen T; Gussio R; Bowlin T; Bavari S.  Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.  Antimicrobial agents and chemotherapy 2009 Oct, 53(10): 4283-91

Panchal RG; Bradfute SB; Peyser BD; Warfield KL; Ruthel G; Lane D; Kenny TA; Anderson AO; Raschke WC; Bavari S.  Reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects of Ebola virus infection.  Cell host & microbe 2009 Aug 20, 6(2): 162-73

Panchal RG, Ulrich RL, Bradfute SB, Lane D, Ruthel G, Kenny TA, Iversen PL, Anderson AO, Gussio R, Raschke WC, Bavari S.  Reduced expression of CD45 protein-tyrosine phosphatase provides protection against anthrax pathogenesis.  Journal of Biological Chemistry 2009 May 8; 284(19): 12874-85

Pittman PR, Liu CT, Cannon TL, Mangiafico JA, Gibbs PH.  Immune interference after sequential alphavirus vaccine vaccinations.  Vaccine 2009 Aug 6, 27(36): 4879-82

Roxas-Duncan V, Enyedy I, Montgomery VA, Eccard VS, Carrington MA, Lai H, Gul N, Yang DCH, Smith LA.  Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A.  Antimicrobial agents and chemotherapy 2009 Aug, 53(8): 3478-86

Rushing SR, Saylor ML, Hale ML.  Translocation of ricin across polarized human bronchial epithelial cells.  Toxicon 2009 Aug; 54(2): 184-191

Rusnak JM, Byrne WR, Chung KN, Gibbs PH, Kim TT, Boudreau EF, Cosgriff T, Pittman P, Kim KY, Erlichman MS, Rezvani DF, Huggins JW.  Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea.  Antiviral research 2009 Jan, 81(1): 68-76

Schmaljohn C.  Vaccines for hantaviruses.  Vaccine 2009 Nov 5, 27 (Suppl 4): D61-4

Smith DR; Lee JS; Jahrling J; Kulesh DA; Turell MJ; Groebner JL; O'Guinn ML.  Development of field-based real-time reverse transcription-polymerase chain reaction assays for detection of Chikungunya and O'nyong-nyong viruses in mosquitoes.  American journal of tropical medicine and hygiene 2009 Oct, 81(4): 679-84

Smith LA.  Botulism and vaccines for its prevention.  Vaccine 2009 Nov 5, 27(Suppl 4): D33-9

Shanks J; Burtnick MN; Brett PJ; Waag DM; Spurgers KB; Ribot WJ; Schell MA; Panchal RG; Gherardini FC; Wilkinson KD; DeShazer D.  Burkholderia mallei tssM encodes a putative deubiquitinase that is secreted and expressed inside infected RAW 264.7 murine macrophages.  Infection and Immunity 2009 Apr; 77 (4): 1636-1648

Stahl AM, Adler M, Millard CB, Gilfillan L.  Accelerating Botulism Therapeutic Product Development in the Department of Defense.  Drug Development Research 2009 June; 70(4, Sp. Iss.): 303-326

Swenson DL; Warfield KL; Warren TK; Lovejoy C; Hassinger JN; Ruthel G; Blouch RE; Moulton HM; Weller DD; Iversen PL; Bavari S.  Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.  Antimicrobial agents and chemotherapy 2009 May; 53(5): 2089-99

Taylor BJ; Orr SA; Chapman JL; Fisher DE.  Beyond-use dating of extemporaneously compounded ketamine, acepromazine, and xylazine: safety, stability, and efficacy over time.  Journal of the American Association for Laboratory Animal Science - JAALAS 2009 Nov, 48(6): 718-26

Taylor SL; Krempel RL; Schmaljohn CS.  Inhibition of TNF-alpha-induced activation of NF-kappaB by hantavirus nucleocapsid proteins.  Annals of the New York Academy of Sciences 2009 Sep, 1171 (Suppl 1): E86-93

Taylor SL, Frias-Staheli N, Garcia-Sastre A, Schmaljohn CS.  Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B.  Journal of virology 2009 Feb, 83(3): 1271-9

Toth SI; Smith LA; Ahmed SA.  Extreme sensitivity of botulinum neurotoxin domains towards mild agitation.  Journal of pharmaceutical sciences 2009 Sep, 98(9): 3302-11

Twenhafel NA, Alves DA, Purcell BK.  Pathology of Inhalational Francisella tularensis spp tularensis SCHU S4 infection in African Green Monkeys (Chlorocebus aethiops).  Veterinary Pathology 2009 July; 46(4): 698-706

Vaughan JA, Focks DA, Turell MJ.  Simulation models examining the effect of Brugian filariasis on dengue epidemics.  American journal of tropical medicine and hygiene 2009 Jan, 80(1): 44-50

Warfield KL, Bradfute SB, Wells J, Lofts L, Cooper MT, Alves DA, Reed DK, VanTongeren SA, Mech CA, Bavari S.  Development and characterization of a mouse model for Marburg hemorrhagic fever.  Journal of Virology 2009 July; 83(13): 6404-15

Webb RP; Smith TJ; Wright P; Brown J; Smith LA.  Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3.  Vaccine 2009 July 16, 27(33): 4490-4497


20132012201120102009200820072006200520042003200220012000

Return to top